Zota Health Care: No Deviation in Preferential Issue Funds for Q4FY26
Zota Health Care Limited reported no deviation in the utilization of funds from preferential issues and QIP for the quarter ended March 31, 2026. The Audit Committee reviewed the statement on May 22, 2026, confirming full utilization against original objectives. Funds were raised through multiple preferential issues and a QIP between August 2024 and February 2026.
The report confirms adherence to regulations regarding fund utilization, which is expected and does not introduce new material information that would significantly impact the company's valuation or operations.
The announcement is a routine compliance filing confirming no deviation in fund utilization, which is a neutral event for the company.
Zota Health Care Limited has submitted its statement of deviation(s) or variation(s) under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the quarter ended March 31, 2026. The company confirmed that there has been no deviation or variation in the utilization of funds raised through preferential issues and Qualified Institutions Placement (QIP).
The Audit Committee of the Board reviewed the statement on May 22, 2026, and noted that the funds raised have been fully utilized against the original objects as of the quarter ended March 31, 2026.
Multiple preferential issues were raised starting from August 14, 2024, to January 20, 2026, with amounts ranging from ₹1156.95 lakhs to ₹4445.07 lakhs. Another preferential issue was raised on April 17, 2025, for ₹7,155.00 lakhs. A Qualified Institutions Placement (QIP) was also conducted on December 17, 2025, raising ₹34,999.99 lakhs.
The stated objects for these fund-raising activities included expansion of DAVAINDIA Project (both FOFO and COCO models), working capital requirements, and general corporate purposes. The total net proceeds available for utilization from these issuances amounted to ₹34,033.24 lakhs. The company, along with its monitoring agency CRISIL Ratings Limited, has confirmed no deviation in the utilization of these funds for the reporting quarter.
What to do with a filing like this
Zota Health Care LImited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Zota Health Care LImited. Read the original for the full detail.